AGL, Cochlear, WiseTech shares: Buy, hold, sell

Find out what brokers expect next for these ASX shares.

AGL Energy Ltd (ASX: AGL), Cochlear Ltd (ASX: COH), and WiseTech Global Ltd (ASX: WTC) shares have all slumped lower over the past month, likely due to macroeconomic headwinds, weaker energy prices, and shifts in investor sentiment.

Here's the latest out of the ASX 200 shares, and what brokers expect next.

Couple looking at their phone surprised, symbolising a bargain buy.

Image source: Getty Images

Brokers rate AGL shares as a SELL

AGL shares are down around 0.1% to $8.31 at the time of writing on Wednesday morning. The ASX energy shares are now down around 4% over the past month and 11% lower year to date.

Over the past month, AGL shares have come under pressure from softer wholesale electricity prices and government regulation changes have also added a layer of uncertainty.

Mild weather, higher renewable energy generation, and battery storage growth are pushing wholesale electricity prices lower and reducing high-price spikes.

At the same time, the government is trying to push for lower costs by introducing price caps and limiting price increases. This could put pressure on AGL's margins going forward.

Brokers are mostly bearish on the outlook for the power company going forward. Market Index data shows the majority of brokers have a sell rating on AGL shares, and the $9.70 average target price implies a downside of around 16%, at the time of writing.

Brokers rate Cochlear shares as a HOLD

Cochlear shares have also slipped further into the red on Wednesday morning. At the time of writing, the shares are down around 0.2% to $129.99 each. The shares are down 7% over the past month and 50% lower year to date.

The shares fell around 14% in late September after the company announced to the ASX that it had received a class action claim filed against it in the Supreme Court of Victoria. 

The claim is on behalf of persons who acquired interests in Cochlear shares between 15 August 2025 and 21 April 2026 (inclusive). It relates to Cochlear's forecast of underlying net profit for FY26. 

Cochlear said it denies the allegations set out in the claim and will be defending the proceedings. But the news rattled investor confidence, and the shares have continued falling ever since.

The update comes off the back of ongoing operational headwinds. Looking ahead to FY27, the ASX healthcare company expects low-single-digit constant currency revenue growth and an underlying net profit between $330 million and $350 million. 

According to Market Index data, the majority of brokers have a hold rating on Cochlear shares. The $126.24 average target price implies a downside of around 3% at the time of writing.

Brokers rate WiseTech shares as a BUY

WiseTech shares are also down on Wednesday morning. At the time of writing, the shares have fallen around 0.5% to $31.79 each. Over the past month, WiseTech shares have tumbled 12%, and they're also down 54% for the year to date.

There hasn't been any price-sensitive news from the company over the past month to explain the latest sell-off. 

But it's been well-documented that the business has been smashed by a combination of headwinds over the past few months. Including an overall investor rotation away from tech shares, a series of regulatory investigations, and governance concerns. 

The company's FY26 results announcement in August didn't help confidence either. On the surface, the earnings result was positive, and earnings were in line with analyst expectations. But its EBITDA figures came in short of market forecasts, and investors rushed to sell up.

But it looks like the experts are still confident that WiseTech shares can bounce back over the next year. Market Index data shows all brokers have a strong buy rating on the shares. The $58.07 target price implies an upside of around 82% at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »